{name}
{subtitle}
Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Participants With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer
city
~8 mi. (Perth, Australia, +247 more cities)
facility
Local Institution
biomarker
ER Positive, +1 more biomarker
drug
anthracycline, +4 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~8 mi. (Perth, Australia, +226 more cities)
facility
Fiona Stanley Hospital ( Site 0162)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~8 mi. (Perth, Australia, +140 more cities)
facility
Royal Perth Hospital ( Site 0002)
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~8 mi. (Perth, Australia, +199 more cities)
facility
Royal Perth Hospital ( Site 0229)
Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
city
~8 mi. (Perth, Australia, +352 more cities)
facility
Perth Children's Hospital
condition
Immature Ovarian Teratoma, +2 more conditions
drug
bleomycin, +3 more drugs
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)
city
~8 mi. (Perth, Australia, +35 more cities)
facility
St John of God Subiaco Hospital ( Site 0051)
drug
favezelimab, +1 more drug
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
city
~8 mi. (Perth, Australia, +165 more cities)
facility
Royal Perth Hospital /ID# 223203
biomarker
del(11)(q10), +27 more biomarkers
drug
navitoclax, +1 more drug